Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP
Kyoung Min Cho, Bhumsuk Keam, Hyerim Ha, Miso Kim, Jae-Woo Jung, Woo-Jung Song, Tae Min Kim, Yoon Kyung Jeon, Hye-Ryun Kang, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo
Korean J Intern Med. 2019;34(4):885-893.   Published online 2017 Nov 20     DOI: https://doi.org/10.3904/kjim.2017.036
Citations to this article as recorded by Crossref logo
Infusion-related reactions to rituximab: frequency, mechanisms and predictors
Franciane Paul, Guillaume Cartron
Expert Review of Clinical Immunology.2019; 15(4): 383.     CrossRef
Is there a relationship between the infusion-related reaction and effect of rituximab in the treatment of patients with diffuse large B-cell lymphoma?
Sang-Gon Park
The Korean Journal of Internal Medicine.2019; 34(4): 775.     CrossRef